stride study semaglutide STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients STRIDE TRIAL: Leading To Early

Prescription Medications: Prescription provided only if clinically appropriate

Be aware of symptoms of both hypoglycemia (dizziness, sweating, confusion) and hyperglycemia (increased thirst, frequent urination, fatigue)

Transforming growth factor- (TGF-) plays a pivotal role in the fbrotic process and is considered a key driver of fibrosis

This creates a negative association with protein foods, making users even less likely to eat enough

The MFDS reviews the Semaglutide KDMF as part of the drug registration process and uses the information provided in the Semaglutide KDMF to evaluate the safety and efficacy of the drug

Potential for higher compensation: If successful, individuals may receive a larger payout compared to class action participants